These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 36567205)

  • 1. Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis.
    Sharma N; Evans TA; Pellicore MJ; Davis E; Aksit MA; McCague AF; Joynt AT; Lu Z; Han ST; Anzmann AF; Lam AN; Thaxton A; West N; Merlo C; Gottschalk LB; Raraigh KS; Sosnay PR; Cotton CU; Cutting GR
    PLoS Genet; 2018 Nov; 14(11):e1007723. PubMed ID: 30444886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of cystic fibrosis by RNA obtained from nasal epithelial cells.
    Prior-de Castro C; Martínez Gallego MÁ; Gómez-González C; de Sancho Martín R; Rodríguez-Antolín C; Rodríguez-Jiménez C; Del Pozo Mate Á; Zamarrón de Lucas E; Ruiz de Valbuena Maiz M; de Manuel Gómez C; Alcolea Batres S; Prados Sánchez MC; J Torres R
    J Cyst Fibros; 2024 Jul; 23(4):788-795. PubMed ID: 38151412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of AlphaMissense data in different protein groups and structural context.
    Tordai H; Torres O; Csepi M; Padányi R; Lukács GL; Hegedűs T
    Sci Data; 2024 May; 11(1):495. PubMed ID: 38744964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients.
    Lago-Docampo M; Tenorio J; Hernández-González I; Pérez-Olivares C; Escribano-Subías P; Pousada G; Baloira A; Arenas M; Lapunzina P; Valverde D
    Sci Rep; 2020 Sep; 10(1):15135. PubMed ID: 32934261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis testing in a referral laboratory: results and lessons from a six-year period.
    Ridge PG; Miller C; Bayrak-Toydemir P; Best DH; Mao R; Swensen JJ; Lyon E; Voelkerding KV
    J Clin Bioinforma; 2013 Jan; 3(1):3. PubMed ID: 23343000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence-Driven Prediction Revealed CFTR Associated with Therapy Outcome of Breast Cancer: A Feasibility Study.
    Kováčová M; Hlaváč V; Koževnikovová R; Rauš K; Gatěk J; Souček P
    Oncology; 2024 Jul; ():1-12. PubMed ID: 39025053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic surgery for a cystic fibrosis-causing splicing mutation.
    Bulcaen M; Carlon MS
    Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101177. PubMed ID: 38261927
    [No Abstract]   [Full Text] [Related]  

  • 8. Splicing mutations in the CFTR gene as therapeutic targets.
    Deletang K; Taulan-Cadars M
    Gene Ther; 2022 Aug; 29(7-8):399-406. PubMed ID: 35650428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
    Kerem E
    Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multi-faceted nature of 15 CFTR exonic variations: Impact on their functional classification and perspectives for therapy.
    Bergougnoux A; Billet A; Ka C; Heller M; Degrugillier F; Vuillaume ML; Thoreau V; Sasorith S; Bareil C; Thèze C; Ferec C; Gac GL; Bienvenu T; Bieth E; Gaston V; Lalau G; Pagin A; Malinge MC; Dufernez F; Lemonnier L; Koenig M; Fergelot P; Claustres M; Taulan-Cadars M; Kitzis A; Reboul MP; Becq F; Fanen P; Mekki C; Audrezet MP; Girodon E; Raynal C
    J Cyst Fibros; 2023 May; 22(3):515-524. PubMed ID: 36567205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exon identity influences splicing induced by exonic variants and in silico prediction efficacy.
    Martin N; Bergougnoux A; Baatallah N; Chevalier B; Varilh J; Baux D; Costes B; Fanen P; Raynal C; Sermet-Gaudelus I; Girodon E; Taulan-Cadars M; Hinzpeter A
    J Cyst Fibros; 2021 May; 20(3):464-472. PubMed ID: 33341408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies.
    Joynt AT; Evans TA; Pellicore MJ; Davis-Marcisak EF; Aksit MA; Eastman AC; Patel SU; Paul KC; Osorio DL; Bowling AD; Cotton CU; Raraigh KS; West NE; Merlo CA; Cutting GR; Sharma N
    PLoS Genet; 2020 Oct; 16(10):e1009100. PubMed ID: 33085659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A classification model relative to splicing for variants of unknown clinical significance: application to the CFTR gene.
    Raynal C; Baux D; Theze C; Bareil C; Taulan M; Roux AF; Claustres M; Tuffery-Giraud S; des Georges M
    Hum Mutat; 2013 May; 34(5):774-84. PubMed ID: 23381846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic, cell biological, and clinical interrogation of the CFTR mutation c.3700 A>G (p.Ile1234Val) informs strategies for future medical intervention.
    Molinski SV; Gonska T; Huan LJ; Baskin B; Janahi IA; Ray PN; Bear CE
    Genet Med; 2014 Aug; 16(8):625-32. PubMed ID: 24556927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-physiopathological consequences of the c.1392G>T CFTR mutation revealed by clinical and cellular investigations.
    Farhat R; El-Seedy A; El-Moussaoui K; Pasquet MC; Adolphe C; Bieth E; Languepin J; Sermet-Gaudelus I; Kitzis A; Ladevèze V
    Biochem Cell Biol; 2015 Feb; 93(1):28-37. PubMed ID: 25403292
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.